期刊文献+

灵芝三萜类成分抑制拓扑异构酶Ⅰ活性的研究 被引量:3

The Inhibition Effect of Triterpenoid in Ganoderma on Topoisomerase Ⅰ
下载PDF
导出
摘要 以灵芝中的三萜类组分(灵芝酸T)为实验药物,考察其对拓扑异构酶Ⅰ活性的影响。结果表明:灵芝酸T能抑制拓扑异构酶Ⅰ活性,且具有浓度依赖性。进一步机理研究表明灵芝酸T可以抑制拓扑异构酶-底物复合物的形成,阻止DNA和酶的相互作用。因此,灵芝酸T属于拓扑异构酶Ⅰ的催化型抑制剂,这可为灵芝中三萜类物质的研究开发提供理论依据。 The triterpenoids components in ganoderma as experimental material were examined on the effect of activity of topoisomerase Ⅰ. The data showed that ganoderic acid T inhibited the activity of topoisomerase Ⅰ behaviors the dose-dependent manner. The inhibition mechanism exploration showed that ganoderic acid T could block the interaction of DNA and topoisomerase Ⅰ by inhibiting the complex formation of the substitute and topoisomerase Ⅰ. The results indicated that ganoderic acid T is a kind of catalysis inhibitor.
作者 唐文
出处 《上海应用技术学院学报(自然科学版)》 2011年第2期90-94,共5页 Journal of Shanghai Institute of Technology: Natural Science
基金 上海市教委科研创新项目(09Y2393)
关键词 灵芝酸 拓扑异构酶 抑制作用 ganoderic acid topoisomerase Ⅰ inhibition
  • 相关文献

参考文献11

  • 1孙忠实,朱珠.抗肿瘤药物的新进展[J].中国医院用药评价与分析,2004,4(1):53-55. 被引量:6
  • 2蒋超,卿晨,蒙凌华,丁健.灵芝提取物对DNA拓扑异构酶的抑制作用及诱导K562细胞凋亡[J].癌症,1999,18(6):661-663. 被引量:26
  • 3Burden D A,Osheroff N.Mechanism of action of euk-arytotic topoisomerase and drugs targeted to this en-zyme. Biochimica et Biophysica Acta . 2003
  • 4Capranico G,Binaschi M,Borgnetto ME,et al.A pro-tein mediated mechanisms for the DNA sequence-spe-cific action of topoisomeraseⅡpoisons. Trends in Pharmacological Sciences . 2001
  • 5Sordet O,Liao Z Y,Liu H,et al.Topoisomerase I-DNA complexes contribute to srsenic trioxide-inducedapoptosis. Journal of Biological Chemistry . 2004
  • 6Dunstan H M,Ludlow C,Goehle S,et al.Cell-basedassays for identification of novel double-strand break-inducing agents. Journal of National Cancer Institute . 2002
  • 7Kang MR,Muller MT,Chung IK.Telomeric DNA damage by topoisomerase I. A possible mechanism for cell killing by camptothecin. Journal of Biological Chemistry . 2004
  • 8Li CH,Chen PY,Chang UM,Kan LS,Fang WH,Tsai KS,Lin SB.Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci . 2005
  • 9Mizushina, Y,T Akihisa,M. Ukiya, et al.A novel DNA topoisomerase inhibitor:dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos. Cancer Science . 2004
  • 10Liu L F.DNA topoisomerase poisons as antitumor drugs. Annual Review of Biochemistry . 1989

二级参考文献34

  • 1谭允育,崔德玉.灵芝水煎剂免疫药理作用的实验研究[J].北京中医药大学学报,1996,19(5):61-62. 被引量:16
  • 2[1]Eaton L.World cancer rates set to double by 2020[J].BMJ, 2003, 326: 728.
  • 3[2]Barman Balfour JA, Goa KL.Bendamustine[J].Drugs, 2001, 61: 631.
  • 4[3]Cvelkovic RS, Figgitt DP, Plosker GL. ET-743[J].Drugs, 2002, 62:1 185.
  • 5[4]McGavin JK, Goa KL. Capecitabine[J]. Drugs, 2001,61:2 309.
  • 6[5]Curran M, Wisenian L.Fulvestrant[J].Drugs, 2001,61: 807.
  • 7[6]Carswell CI, Figgitt DP.Bicalutamide[J].Drugs,2002, 62: 2471.
  • 8[7]Mitlak BH, Cohen FJ.Selective estrogen receptor modulators[J].Drugs, 1999, 57: 653.
  • 9[8]Culy CR, Clemett D,Wiseman LR.Oxaliplatin[J].Drugs, 2000, 60:895.
  • 10[9]Figgitt DP, Wiseman LR.Docetaxel[J].Drugs, 2000,59: 621.

共引文献30

同被引文献59

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部